Lymphomas [clinicaltrials_resource:9bb660c064371ec3b4cd320c64d98468]
Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer [clinicaltrials:NCT00006518]Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas [clinicaltrials:NCT00023166]Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas [clinicaltrials:NCT00152126]clinicaltrials:NCT00167180Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy [clinicaltrials:NCT00222443]Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas [clinicaltrials:NCT00389077]Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma [clinicaltrials:NCT00396864]Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies [clinicaltrials:NCT00513318]Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas [clinicaltrials:NCT00553189]Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas [clinicaltrials:NCT00592163]A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma [clinicaltrials:NCT00725634]Assess the Oral Bioavailability of New ABT-263 Formulations [clinicaltrials:NCT00743028]Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas [clinicaltrials:NCT00788099]Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy [clinicaltrials:NCT00796562]Collection of Tissue Samples for Cancer Research [clinicaltrials:NCT00900198]clinicaltrials:NCT00947739clinicaltrials:NCT00968864R Retreatment in 1st Relapsed DLBCL [clinicaltrials:NCT00980304]Refinement of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Via Cognitive Interviewing and Usability Testing [clinicaltrials:NCT01031641]Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours [clinicaltrials:NCT01194193]Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant [clinicaltrials:NCT01200017]clinicaltrials:NCT01237236clinicaltrials:NCT01273155Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects [clinicaltrials:NCT01359982]Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting [clinicaltrials:NCT01387841]Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas [clinicaltrials:NCT01490047]A Study of Alisertib (MLN8237) in Adult East Asian Patients With Advanced Solid Tumors or Lymphomas [clinicaltrials:NCT01512758]A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval [clinicaltrials:NCT01525394]Treatment of CD20 Antibody Plus CIK for Patients With Refractory Lymphomas [clinicaltrials:NCT01828008]Bronchoscopic Sampling Techniques in Sarcoidosis [clinicaltrials:NCT01836822]clinicaltrials:NCT01851369A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas [clinicaltrials:NCT02048488]A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001 [clinicaltrials:NCT02096341]Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology [clinicaltrials:NCT02140736]clinicaltrials:NCT02169791CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273) [clinicaltrials:NCT02274584]Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies [clinicaltrials:NCT02355535]Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 in Adults With Advanced Solid Tumors and Lymphomas [clinicaltrials:NCT02392611]Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation. [clinicaltrials:NCT02452099]
condition [clinicaltrials_vocabulary:condition]
Lymphomas [clinicaltrials_resource:9bb660c064371ec3b4cd320c64d98468]
Bio2RDF identifier
9bb660c064371ec3b4cd320c64d98468
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9bb660c064371ec3b4cd320c64d98468
identifier
clinicaltrials_resource:9bb660c064371ec3b4cd320c64d98468
title
Lymphomas
@en
label
Lymphomas [clinicaltrials_resource:9bb660c064371ec3b4cd320c64d98468]
@en